Home

maturitate Izola Armistiţiu easl guideline nafld biomarkers table Rang jeton titlu

EASL clinical practice guidelines for the management of occupational liver diseases - Colombo - 2020 - Liver International - Wiley Online Library
EASL clinical practice guidelines for the management of occupational liver diseases - Colombo - 2020 - Liver International - Wiley Online Library

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management

Links To And Excerpts From "Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis" - Tom Wade MD
Links To And Excerpts From "Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis" - Tom Wade MD

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update - ScienceDirect
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update - ScienceDirect

Frontiers | Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
Frontiers | Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients

Frontiers | Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease
Frontiers | Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update - Journal of Hepatology
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update - Journal of Hepatology

JCM | Free Full-Text | Nonalcoholic Steatohepatitis: A 9-Year Follow Up Cohort Study
JCM | Free Full-Text | Nonalcoholic Steatohepatitis: A 9-Year Follow Up Cohort Study

Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges.
Summary from EASL 2021 for Hepatitis B, C, D and fatty liver disease. Liver disease in 2021: advances and remaining challenges.

Quality standards for the management of non-alcoholic fatty liver disease ( NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group -
Quality standards for the management of non-alcoholic fatty liver disease ( NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group -

Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult | Egyptian Liver Journal | Full Text
Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult | Egyptian Liver Journal | Full Text

PDF] EASL Clinical Practice Guideline: Occupational liver diseases. | Semantic Scholar
PDF] EASL Clinical Practice Guideline: Occupational liver diseases. | Semantic Scholar

Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | Semantic Scholar

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice

Non-Alcoholic Fatty Liver Disease (NAFLD) — EACS Guidelines
Non-Alcoholic Fatty Liver Disease (NAFLD) — EACS Guidelines

Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review | Journal of Health Reports and Technology | Full Text
Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review | Journal of Health Reports and Technology | Full Text

Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease - JHEP Reports
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease - JHEP Reports

Advancing the global public health agenda for NAFLD: a consensus statement | Nature Reviews Gastroenterology & Hepatology
Advancing the global public health agenda for NAFLD: a consensus statement | Nature Reviews Gastroenterology & Hepatology

Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

The diagnostic conundrum in non-alcoholic fatty liver disease
The diagnostic conundrum in non-alcoholic fatty liver disease

PDF] Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis | Semantic Scholar
PDF] Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis | Semantic Scholar

Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications